+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

3D Printed Drugs Market by Technology, Dose Form, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4857884
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The 3D Printed Drugs Market grew from USD 292.72 million in 2023 to USD 331.22 million in 2024. It is expected to continue growing at a CAGR of 14.26%, reaching USD 744.29 million by 2030.

3D printed drugs represent a cutting-edge frontier in pharmaceuticals, utilizing additive manufacturing to create medications with precise dosages, tailored release profiles, and complex structures not achievable through traditional methods. This innovation is crucial for personalized medicine, allowing customization of drug formulations to suit individual patient needs, potentially improving efficacy, reducing side effects, and enhancing patient compliance. Applications of 3D printed drugs span from rapid prototyping to on-demand production in hospitals, clinics, and even home settings. The end-use scope primarily focuses on personalized healthcare, pediatrics, geriatrics, and rare disease management, where individualized dosing can be critical. Market growth is propelled by factors like technological advancements in 3D printing, increasing prevalence of chronic diseases, and rising demand for personalization in therapeutic interventions. The recent FDA approval of the first 3D printed drug, Spritam for epilepsy, exemplifies regulatory openness and paves the way for further pharmaceutical innovations. Opportunities abound in developing new drug delivery systems and multifunctional drug compositions, along with establishing collaborations between pharmaceutical companies and tech firms to enhance printing technologies. However, challenges such as the high cost of 3D printing technology, regulatory hurdles, and limited material availability could hinder rapid market expansion. Intellectual property concerns and the need for rigorous quality control also pose significant obstacles. Innovations might focus on material development, particularly biodegradable and bio-compatible materials, improved software for precise drug formulations, and hybrid 3D printing techniques that enable combination therapies or multitask medications. For businesses, focusing on partnerships with medical institutions for R&D, investing in proprietary technology, and engaging with regulatory bodies to streamline approval processes are strategic pathways for growth. Overall, the market is dynamic yet complex, demanding strategic navigation to leverage technological advancements and evolving healthcare demands effectively.

Understanding Market Dynamics in the 3D Printed Drugs Market

The 3D Printed Drugs Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Surge in demand for instantaneous soluble drugs
    • Growing adoption of personalized drugs and the production of combination medicine
    • Extensive use of 3D printed technology for manufacturing cancer drugs
  • Market Restraints
    • Material limitations associated with manufacturing of 3D printed drugs
  • Market Opportunities
    • Constant technological developments in 3D printing technique
    • Significant investments for manufacturing of 3D printed pharmaceuticals
  • Market Challenges
    • Complexities in manufacturing of 3D printed drugs

Exploring Porter’s Five Forces for the 3D Printed Drugs Market

Porter’s Five Forces framework further strengthens the insights of the 3D Printed Drugs Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the 3D Printed Drugs Market

External macro-environmental factors deeply influence the performance of the 3D Printed Drugs Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the 3D Printed Drugs Market

The 3D Printed Drugs Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the 3D Printed Drugs Market

The 3D Printed Drugs Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the 3D Printed Drugs Market

The 3D Printed Drugs Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the 3D Printed Drugs Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., 3DR HOLDINGS, Anatomics Pty Ltd, Aprecia Pharmaceuticals, LLC, AstraZeneca plc, BioDuro, LLC, Biomedical Modeling Inc., Cycle Pharmaceuticals, Cyfuse Biomedical K.K., EnvisionTEC GmbH, FabRx Ltd., General Electric Company, GlaxoSmithKline Plc, Materialise NV, Merck KGaA, Organovo Holdings Inc., Proto Labs Inc., Renishaw PLC, Rokit Healthcare Inc., Siemens AG, Stratasys Ltd., Triastek, Inc., TVASTA, Yissum, and Zortrax S.A..

Market Segmentation & Coverage

This research report categorizes the 3D Printed Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Technology
    • Direct-Write
    • Fused Deposition Modelling
    • Inkjet Printing
    • Powder Bed Printing
    • Stereolithography
    • Zip Dose
  • Dose Form
    • Capsule
    • Nanoparticles
    • Tablet
  • Application
    • Dental
    • Neurology
    • Orthopedic
  • End-User
    • Clinics & Hospitals
    • Research Laboratories
    • Speciality Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in demand for instantaneous soluble drugs
5.1.1.2. Growing adoption of personalized drugs and the production of combination medicine
5.1.1.3. Extensive use of 3D printed technology for manufacturing cancer drugs
5.1.2. Restraints
5.1.2.1. Material limitations associated with manufacturing of 3D printed drugs
5.1.3. Opportunities
5.1.3.1. Constant technological developments in 3D printing technique
5.1.3.2. Significant investments for manufacturing of 3D printed pharmaceuticals
5.1.4. Challenges
5.1.4.1. Complexities in manufacturing of 3D printed drugs
5.2. Market Segmentation Analysis
5.2.1. Technology: Direct-write technology provides personalized and effective medication solutions
5.2.2. Dose Form: Potential adoption of 3D printed drugs in the form of capsule
5.2.3. Application: Proliferating use for manufacturing of neurology drugs
5.2.4. End-User: Significant penetration of 3D printed drugs in clinics & hospitals
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. 3D Printed Drugs Market, by Technology
6.1. Introduction
6.2. Direct-Write
6.3. Fused Deposition Modelling
6.4. Inkjet Printing
6.5. Powder Bed Printing
6.6. Stereolithography
6.7. Zip Dose
7. 3D Printed Drugs Market, by Dose Form
7.1. Introduction
7.2. Capsule
7.3. Nanoparticles
7.4. Tablet
8. 3D Printed Drugs Market, by Application
8.1. Introduction
8.2. Dental
8.3. Neurology
8.4. Orthopedic
9. 3D Printed Drugs Market, by End-User
9.1. Introduction
9.2. Clinics & Hospitals
9.3. Research Laboratories
9.4. Speciality Clinics
10. Americas 3D Printed Drugs Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific 3D Printed Drugs Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa 3D Printed Drugs Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Triastek and BioNTech partner to develop 3D printed RNA therapeutics for oral delivery, aiming for over USD 1.2 billion in milestone payments
13.3.2. Carcinotech raises GBP 4.2 million for US expansion, enhancing 3D-printed micro-tumour tech for personalized oncology drug development
13.3.3. CurifyLabs Launches 3D Printing Solution For Personalised Medicine
13.3.4. Cellink And Carcinotech Partner To Transform Cancer Drug Development With 3d Bioprinting
13.3.5. Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. 3D PRINTED DRUGS MARKET RESEARCH PROCESS
FIGURE 2. 3D PRINTED DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2030 (%)
FIGURE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. 3D PRINTED DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. 3D PRINTED DRUGS MARKET DYNAMICS
TABLE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 41. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 45. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 63. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 67. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 75. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 99. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 112. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 116. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 120. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 124. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 128. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 136. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 148. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 152. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 156. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 172. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 184. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the 3D Printed Drugs Market, which are profiled in this report, include:
  • 3D Systems, Inc.
  • 3DR HOLDINGS
  • Anatomics Pty Ltd
  • Aprecia Pharmaceuticals, LLC
  • AstraZeneca plc
  • BioDuro, LLC
  • Biomedical Modeling Inc.
  • Cycle Pharmaceuticals
  • Cyfuse Biomedical K.K.
  • EnvisionTEC GmbH
  • FabRx Ltd.
  • General Electric Company
  • GlaxoSmithKline Plc
  • Materialise NV
  • Merck KGaA
  • Organovo Holdings Inc.
  • Proto Labs Inc.
  • Renishaw PLC
  • Rokit Healthcare Inc.
  • Siemens AG
  • Stratasys Ltd.
  • Triastek, Inc.
  • TVASTA
  • Yissum
  • Zortrax S.A.

Methodology

Loading
LOADING...

Table Information